You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):擬將“強力枇杷露”藥品品種的所有權以不低於公司成本價的價格轉讓給康普藥業

格隆匯7月22日丨方盛製藥(603998.SH)公佈,爲進一步有效發揮公司的藥品批文價值,提高資產運營效率,公司擬與康普藥業股份有限公司(簡稱“康普藥業”)在產品方面展開戰略合作,雙方將根據各自的優勢和產品,採取產品互換、渠道共享等方式在產品方面展開合作。爲貫徹落實上述合作事項,經董事長審批同意,2025年7月21日,公司及滕王閣藥業與康普藥業簽訂《藥品上市許可轉讓協議》,同意將“強力枇杷露”藥品品種的所有權以不低於公司成本價的價格轉讓給康普藥業,該交易金額在公司董事長審批權限範圍內。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account